Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).
about
Variability in Clinical and Anatomical Manifestation of Velocardiofacial Syndrome Presents Diagnostic and Policy Uncertainty.Patterns of Allergic Sensitization in High IgE Syndromes.Graves' Disease in Pediatric and Elderly Patients with 22q11.2 Deletion Syndrome.Congenital anomalies and rhabdoid tumor associated with 22q11 germline deletion and somatic inactivation of the SMARCB1 tumor suppressor.Immune Dysfunction in Children with CHARGE Syndrome: A Cross-Sectional Study.22q11.2 deletion syndromeSignature MicroRNA expression patterns identified in humans with 22q11.2 deletion/DiGeorge syndromeTransgenic expression of microRNA-185 causes a developmental arrest of T cells by targeting multiple genes including Mzb1.Clinical predictors of autoimmune and severe atopic disease in pediatric heart transplant recipients.Head and neck manifestations of 22q11.2 deletion syndromes.Immunological aspects of 22q11.2 deletion syndrome.New frontiers in primary immunodeficiency disorders: immunology and beyond….Immunodeficiencies Associated with Abnormal Newborn Screening for T Cell and B Cell Lymphopenia.Adoptive transfer of autologous T cells improves T-cell repertoire diversity and long-term B-cell function in pediatric patients with neuroblastoma.Clinical Phenotype of DiGeorge Syndrome with Negative Genetic Tests: A Case of DiGeorge-Like Syndrome?Modulating Neuroinflammation to Treat Neuropsychiatric Disorders.Increased Levels of Interferon-Inducible Protein 10 (IP-10) in 22q11.2 Deletion Syndrome.Autoimmunity associated with chemically induced thymic dysplasia.A prospective study of influenza vaccination and a comparison of immunologic parameters in children and adults with chromosome 22q11.2 deletion syndrome (digeorge syndrome/velocardiofacial syndrome).Variable immune deficiency related to deletion size in chromosome 22q11.2 deletion syndrome.The immune deficiency of chromosome 22q11.2 deletion syndrome.
P2860
Q30244646-D5B32369-68CC-4A3A-9D55-C3FD27CB09AAQ30278478-F1A533D1-D4FF-42D5-9959-5F7CA53F5FA9Q32182385-0C6DAA21-A5E6-41A7-B5D7-5CB0CE57C1E5Q34786042-4AF1621C-D3D4-468A-B0D9-DFCAD30CBD4CQ36257777-CA0EA53D-F63E-4E6E-B082-63B68D6A70FEQ36988231-2684ECB5-AC58-4B8F-9169-5146562CEACAQ37108404-2203FAAD-4B12-4A38-802C-87A5061EE060Q37234148-E0A03626-2F1A-4D66-952C-EBA0261D56CBQ37705233-D48CA8F1-FD67-4F27-AB70-151F8BA5B315Q37921180-509FBDB9-3187-489E-B02E-82348693C1E9Q37943798-7A294357-3BDD-4EEA-B8E2-BD097EA280A9Q37947135-B07192EC-C1B8-4867-9B8A-0632EB928C9AQ39206354-0543BDF4-8F22-4EC7-8275-75A7391C5985Q41151666-83FA9FDA-C689-42D3-BD5E-6F4907F7F9ABQ41452524-EAE81454-6E7B-42E5-81B0-33E4F911A4C2Q47140966-F0BDDED1-B26E-48ED-A00E-811A64B7D40FQ48273912-8935252A-B55D-49AE-B30C-623C7B89FEF0Q48636789-56D1F165-80A8-4B97-B479-E070E21ADDBFQ51168850-8438E5A7-CC29-40B8-8C57-88C255DBEB19Q52713279-1F9C89B1-5160-4583-9684-6AE6E00CAA2BQ52765219-00B40C58-EABF-47B8-AA74-555769A09544
P2860
Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Secondary immunologic conseque ...... me/velocardiofacial syndrome).
@en
Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome
@nl
type
label
Secondary immunologic conseque ...... me/velocardiofacial syndrome).
@en
Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome
@nl
prefLabel
Secondary immunologic conseque ...... me/velocardiofacial syndrome).
@en
Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome
@nl
P2093
P2860
P1433
P1476
Secondary immunologic conseque ...... ome/velocardiofacial syndrome)
@en
P2093
D McDonald-McGinn
E Luning Prak
K McDonald
P2860
P304
P356
10.1016/J.CLIM.2010.04.011
P577
2010-05-15T00:00:00Z